[(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate

C71H122F3N13O15 — CID 90142721

IUPAC[(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate
SMILESC/C=C/C[C@@H](C)[C@@H](OC(C)=O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N[C@@H]([C@H](C)COCC(=O)N2CCN(CC(F)(F)F)CC2)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
InChIInChI=1S/C71H122F3N13O15/c1-25-27-28-44(13)59(102-49(18)88)58-64(94)77-50(26-2)66(96)80(19)48(17)61(91)79-56(45(14)36-101-37-54(89)87-31-29-86(30-32-87)38-71(72,73)74)63(93)78-55(42(9)10)69(99)81(20)51(33-39(3)4)62(92)75-46(15)60(90)76-47(16)65(95)82(21)52(34-40(5)6)67(97)83(22)53(35-41(7)8)68(98)84(23)57(43(11)12)70(100)85(58)24/h25,27,39-48,50-53,55-59H,26,28-38H2,1-24H3,(H,75,92)(H,76,90)(H,77,94)(H,78,93)(H,79,91)/b27-25+/t44-,45-,46+,47-,48-,50+,51+,52+,53+,55+,56+,57+,58+,59-/m1/s1
InChIKeyDMHBPOLIXLILIG-HBBLYIORSA-N
MW1454.83 g/mol
LogP3.20
Rot. Bonds20

About [(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate

[(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate (PubChem CID 90142721) has the molecular formula C71H122F3N13O15 and a molecular weight of 1454.83 g/mol. Its IUPAC name is [(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate.

Molecular Properties

Compound Name[(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate
PubChem CID90142721
Molecular FormulaC71H122F3N13O15
Molecular Weight1454.83 g/mol
Exact Mass1453.91
IUPAC Name[(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate
SMILESC/C=C/C[C@@H](C)[C@@H](OC(C)=O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N[C@@H]([C@H](C)COCC(=O)N2CCN(CC(F)(F)F)CC2)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C
InChIInChI=1S/C71H122F3N13O15/c1-25-27-28-44(13)59(102-49(18)88)58-64(94)77-50(26-2)66(96)80(19)48(17)61(91)79-56(45(14)36-101-37-54(89)87-31-29-86(30-32-87)38-71(72,73)74)63(93)78-55(42(9)10)69(99)81(20)51(33-39(3)4)62(92)75-46(15)60(90)76-47(16)65(95)82(21)52(34-40(5)6)67(97)83(22)53(35-41(7)8)68(98)84(23)57(43(11)12)70(100)85(58)24/h25,27,39-48,50-53,55-59H,26,28-38H2,1-24H3,(H,75,92)(H,76,90)(H,77,94)(H,78,93)(H,79,91)/b27-25+/t44-,45-,46+,47-,48-,50+,51+,52+,53+,55+,56+,57+,58+,59-/m1/s1
InChIKeyDMHBPOLIXLILIG-HBBLYIORSA-N
XLogP3.20
TPSA326.44 Ų
H-Bond Donors5
H-Bond Acceptors16
Rotatable Bonds20
Heavy Atoms102
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001454.83
LogP ≤ 53.20
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze [(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate?
The IUPAC name of [(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate (CID 90142721) is [(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate.
What is the SMILES notation for [(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate?
The canonical SMILES for [(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate is C/C=C/C[C@@H](C)[C@@H](OC(C)=O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)[C@H](C)C(=O)N[C@@H]([C@H](C)COCC(=O)N2CCN(CC(F)(F)F)CC2)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C.
What is the InChIKey of [(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate?
The InChIKey is DMHBPOLIXLILIG-HBBLYIORSA-N. The full InChI is InChI=1S/C71H122F3N13O15/c1-25-27-28-44(13)59(102-49(18)88)58-64(94)77-50(26-2)66(96)80(19)48(17)61(91)79-56(45(14)36-101-37-54(89)87-31-29-86(30-32-87)38-71(72,73)74)63(93)78-55(42(9)10)69(99)81(20)51(33-39(3)4)62(92)75-46(15)60(90)76-47(16)65(95)82(21)52(34-40(5)6)67(97)83(22)53(35-41(7)8)68(98)84(23)57(43(11)12)70(100)85(58)24/h25,27,39-48,50-53,55-59H,26,28-38H2,1-24H3,(H,75,92)(H,76,90)(H,77,94)(H,78,93)(H,79,91)/b27-25+/t44-,45-,46+,47-,48-,50+,51+,52+,53+,55+,56+,57+,58+,59-/m1/s1.
What are the key properties of [(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate?
[(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate has a molecular weight of 1454.83 g/mol, XLogP of 3.20, 20 rotatable bonds, 5 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for [(E,1R,2R)-1-[(2S,5S,8R,11S,14S,17S,20S,23R,26S,29S,32S)-5-ethyl-1,7,8,16,20,23,25,28,31-nonamethyl-17,26,29-tris(2-methylpropyl)-3,6,9,12,15,18,21,24,27,30,33-undecaoxo-11-[(2S)-1-[2-oxo-2-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]ethoxy]propan-2-yl]-14,32-di(propan-2-yl)-1,4,7,10,13,16,19,22,25,28,31-undecazacyclotritriacont-2-yl]-2-methylhex-4-enyl] acetate is sourced from PubChem (CID 90142721), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).